ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon plans 0-million capex in two years
Biocon plans a 0 million capital expenditure, allocating 0 million to biologics, primarily enhancing Malaysian capacities, and million to generics. Fueled by strong generics growth and biosimilar progress, Q4 net profit surged 153%. The company l
Announcement as on 10 May 2025

Biocon Biologics secures multiple market access agreements in US for Yesintek
Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Multiple formularies, including Express Scripts, Cigna, and UnitedHealthcare, will include Yesintek starting in 2025. Thi
Announcement as on 05 May 2025

Biocon Biologics secures market entry for Yesafili in US
Biocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili, its biosimilar to Eylea. The agreement allows Biocon Biologics to launch Yesafili in the US by the second half of 2
Announcement as on 15 April 2025

Market Trading Guide: Indigo, Biocon among 4 stock recommendations for Wednesday
Nifty fell for the 10th straight session, marking its longest losing streak since 1996, while Sensex recorded its third consecutive decline. Analysts suggest Nifty is finding support around 21,800–22,000, with a potential short-term recovery unless it de
Announcement as on 04 March 2025

Biocon launches diabetes, obesity management drug in UK
Biocon has launched Liraglutide, a drug for diabetes and obesity management, in the UK under the brand names Liraglutide Biocon and Biolide. This follows approval from the UK's MHRA, making Biocon the first generics company to gain such approval in a major
Announcement as on 28 February 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 384.66
  • 12Day Average: 388.63
  • 20Day Average: 396.72
  • 50Day Average: 415.17
  • 100Day Average: 413.34
  • 150Day Average: 399.53
  • 200Day Average: 395.15

532523 Indicators & signals

Indicator MACD (12,26,9)

390.44, 398.69, -8.5
Indicator MACD is in negative zone

Indicator ADX (14)

11.37, 20.54, 25.81
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Tue Sep 2026 389.25 389.00 to 399.00 -1.46% 0.04 times
21 Mon Sep 2026 395.00 387.55 to 396.00 2.6% 0.06 times
18 Fri Sep 2026 385.00 379.50 to 388.80 1.32% 0.05 times
17 Thu Sep 2026 380.00 370.45 to 381.75 1.59% 0.03 times
16 Wed Sep 2026 374.05 374.00 to 383.70 -1.82% 0.04 times
15 Tue Sep 2026 381.00 381.00 to 392.50 -2.55% 0.06 times
11 Fri Sep 2026 390.95 384.80 to 396.65 0.24% 0.05 times
10 Thu Sep 2026 390.00 388.65 to 397.50 -1.27% 0.06 times
09 Wed Sep 2026 395.00 393.10 to 403.95 0.62% 9.42 times
08 Tue Sep 2026 392.55 390.90 to 399.50 -0.24% 0.07 times
07 Mon Sep 2026 393.50 388.70 to 397.25 -0.94% 0.16 times
04 Fri Sep 2026 397.25 396.50 to 404.80 -1.18% 0.04 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top